COVID recovered patients to suffer from fatigue, shortness of breath for a year: Study
By Team Newsable | First Published Aug 27, 2021, 11:28 AM ISTAfter a year, about half of patients discharged from the hospital for Covid still have at least one persisting symptom, most often tiredness or muscular weakness, according to research published on Friday in the British medical journal The Lancet.
According to new Chinese research asking for a deeper understanding of the pandemic's long-term health impacts, many patients still suffer from fatigue and shortness of breath a year after being hospitalised for COVID-19. After a year, about half of patients discharged from the hospital for Covid still have at least one persisting symptom, most often tiredness or muscular weakness, according to research published on Friday in the British medical journal The Lancet.
The most extensive study on the disease known as "long Covid" also found that one in every three patients still had shortness of breath a year after being diagnosed.
This figure is significantly greater among people who have been badly affected by the disease.
Latest Videos
Also Read | Delta variant infects both vaccinated, unvaccinated; reduces mortality among inoculated: ICMR study
"With no proven therapies or even rehabilitative advice, lengthy COVID impairs people's ability to resume regular life and employment," the Lancet said on an editorial accompanying the research. The study suggests that full recovery from COVID-19 will take more than a year for many individuals.
The study followed almost 1,300 persons hospitalised with COVID in Wuhan, China's capital city, which was the first to be affected by the pandemic, which has since infected 214 million people and killed over 4 million. After six months, the proportion of observed patients having at least one symptom fell from 68 per cent to 49 per cent after a year.
According to the study, respiratory pain rose from 26 per cent of participants after six months to 30 per cent after a year.
Also Read | Moderna 76%, Pfizer 42% effective against COVID-19 Delta variant: Mayo Clinic study
It discovered that afflicted women were 43 per cent more likely than affected males to experience fatigue or chronic physical weakness. They were twice as likely to be diagnosed with anxiety or depression. The study said that 88 per cent of patients who worked before their diagnosis had returned to work a year later. The study adds to prior studies that cautioned authorities in many nations to be prepared to give long-term assistance to Covid-affected health personnel and patients.
subscribe to Asianet Newsable WhatsApp channel by clicking here. For more reliable and latest news
subscribe to Asianet Newsable Telegram channel by clicking here.